Publikationen, an denen er mitarbeitet Alfonso Cabello (8)

2023

  1. Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study—The U-SEX-2 GESIDA 9416 Study

    Journal of Clinical Medicine, Vol. 12, Núm. 23

2022

  1. Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817)

    PloS one, Vol. 17, Núm. 3, pp. e0266191

2020

  1. Randomized Trial Evaluating the Neurotoxicity of Dolutegravir/Abacavir/Lamivudine and Its Reversibility after Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: GESIDA 9016

    Open Forum Infectious Diseases, Vol. 7, Núm. 12

2019

  1. Alternative switching strategies based on regimens with a low genetic barrier: do clinicians have a choice nowadays?

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 3, pp. 423-426

  2. Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIda 9416 study

    PLoS ONE, Vol. 14, Núm. 12

2018

  1. Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study

    PLoS ONE, Vol. 13, Núm. 6

  2. Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study

    AIDS Patient Care and STDs, Vol. 32, Núm. 3, pp. 112-118

2016

  1. Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 12, pp. 3510-3514